title: Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants.
authors: Hematology Department, Hospital del Mar-IMIM, UAB-UPF, Passeig Marítim 25-29, 08003, Barcelona, Spain.
authors: Ana Sofia
authors: AS
authors: de Freitas
authors: Hematology Department, Hospital del Mar-IMIM, UAB-UPF, Passeig Marítim 25-29, 08003, Barcelona, Spain. 95967@parcdesalutmar.cat.
authors: Alberto
authors: A
authors: Alvarez-Larrán
mesh_terms: D000074:Acenocoumarol / Q000627:therapeutic use*; D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000150:complications / Q000188:drug therapy*; D016016:Proportional Hazards Models; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D000074:Acenocoumarol